Farletuzumab MMAE is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab conjugated to MMAE.
Molecular Weight:
150620
Purity:
98.0%
* VAT and and shipping costs not included. Errors and price changes excepted
